The targeting of diverse antigens to Treml4+ cDC1 by anti-Treml4 antibodies elicited both CD4+ and CD8+ T cell responses, but the effects of antigen delivery on disease severity in various models, including tumor transplantation and EAE, remain to be more fully elucidated [46,66]. Here, CD8A is linked to neoplasm.